Glenmark Pharmaceuticals
GLENMARK.NS
#2701
Rank
โ‚ฌ4.83 B
Marketcap
17,15ย โ‚ฌ
Share price
-2.59%
Change (1 day)
110.71%
Change (1 year)

EPS for Glenmark Pharmaceuticals (GLENMARK.NS)

EPS in 2023 (TTM): 0,11ย โ‚ฌ

According to Glenmark Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is 0,10ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,37ย โ‚ฌ a decrease over its 2021 EPS that were of 0,46ย โ‚ฌ.

EPS history for Glenmark Pharmaceuticals from 2012 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,11ย โ‚ฌ-68.88%
20220,37ย โ‚ฌ-20.18%
20210,46ย โ‚ฌ7.13%
20200,43ย โ‚ฌ25.72%
20190,34ย โ‚ฌ-22.01%
20180,44ย โ‚ฌ30.15%
20170,34ย โ‚ฌ-34.82%
20160,52ย โ‚ฌ63.09%
20150,32ย โ‚ฌ9.68%
20140,29ย โ‚ฌ-26.58%
20130,39ย โ‚ฌ0.51%
20120,39ย โ‚ฌ